日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching

通过倾向评分匹配的比较分析验证新诊断胶质母细胞瘤患者术前新辅助贝伐珠单抗治疗的有效性

Yamamoto, Yohei; Teshigawara, Akihiko; Tamura, Ryota; Takei, Jun; Morimoto, Yukina; Tomoto, Kyoichi; Akasaki, Yasuharu; Hasegawa, Yuzuru; Murayama, Yuichi; Miyake, Keisuke; Sasaki, Hikaru; Tanaka, Toshihide

An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma

一项探索性前瞻性 II 期研究,旨在评估术前新辅助贝伐珠单抗和替莫唑胺治疗新诊断的胶质母细胞瘤的疗效。

Tanaka, Toshihide; Tamura, Ryota; Takei, Jun; Morimoto, Yukina; Teshigawara, Akihiko; Yamamoto, Yohei; Imai, Ryotaro; Kuranari, Yuki; Tohmoto, Kyoichi; Hasegawa, Yuzuru; Akasaki, Yasuharu; Murayama, Yuichi; Miyake, Keisuke; Sasaki, Hikaru

Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment

更正:贝伐单抗治疗期间及治疗后切除的胶质母细胞瘤中替代血管生成途径的状态

Ezaki, Taketo; Tanaka, Toshihide; Tamura, Ryota; Ohara, Kentaro; Yamamoto, Yohei; Takei, Jun; Morimoto, Yukina; Imai, Ryotaro; Kuranari, Yuki; Akasaki, Yasuharu; Toda, Masahiro; Murayama, Yuichi; Miyake, Keisuke; Sasaki, Hikaru

Comparative analyses of erythroblast transformation specific-1 related gene expression before and after neoadjuvant bevacizumab therapy for newly diagnosed glioblastoma

对新诊断的胶质母细胞瘤患者新辅助贝伐珠单抗治疗前后红细胞转化特异性-1相关基因表达的比较分析

Iwauchi, Ai; Fukasawa, Nei; Takei, Jun; Maeda, Miku; Tomoto, Kyoichi; Teshigawara, Akihiko; Yamamoto, Yohei; Akasaki, Yasuharu; Hasegawa, Yuzuru; Murayama, Yuichi; Miyake, Keisuke; Shimoda, Masayuki; Tanaka, Toshihide

Mastocytosis in a Case of Noonan Syndrome Caused by a De Novo Pathogenic CBL Variant

由新生致病性CBL变异引起的努南综合征中的肥大细胞增多症

Kawaguchi, Tatsuya; Okanishi, Tohru; Okazaki, Tetsuya; Aoki, Chisako; Kasagi, Noriko; Adachi, Kaori; Yoshida, Yuichi; Miyake, Noriko; Matsumoto, Naomichi; Maegaki, Yoshihiro

PATH-44. THE LANDSCAPE OF SOMATIC MUTATIONS AND COPY NUMBER ALTERATIONS IN PRIMARY GLIOBLASTOMA IN JAPAN

PATH-44. 日本原发性胶质母细胞瘤体细胞突变和拷贝数变异的概况

Abdulla, S; Tanaka, Toshihide; Tamura, Ryota; Takei, Jun; Morimoto, Yukina; Teshigawara, Akihiko; Tohmoto, Kyoichi; Kuranari, Yuki; Imai, Ryotaro; Yamamoto, Yohei; Hasegawa, Yuzuru; Akasaki, Yasuharu; Murayama, Yuichi; Miyake, Keisuke; Sasaki, Hikaru; Umehara, Toru; Arita, Hideyuki; Ema, Yoshioka; Shofuda, Tomoko; Kinoshita, Manabu; Kodama, Yoshinori; Kagawa, Naoki; Fujimoto, Yasunori; Okita, Yoshiko; Nonaka, Masahiro; Uda, Takehiro; Fukai, Junya; Fujita, Koji; Sakamoto, Daisuke; Mori, Kanji; Kishima, Haruhiko; Kanemura, Yonehiro

Causes of Death in Patients with Severe Aortic Stenosis: An Observational study

重度主动脉瓣狭窄患者的死亡原因:一项观察性研究

Minamino-Muta, Eri; Kato, Takao; Morimoto, Takeshi; Taniguchi, Tomohiko; Shiomi, Hiroki; Nakatsuma, Kenji; Shirai, Shinichi; Ando, Kenji; Kanamori, Norio; Murata, Koichiro; Kitai, Takeshi; Kawase, Yuichi; Miyake, Makoto; Izumi, Chisato; Mitsuoka, Hirokazu; Kato, Masashi; Hirano, Yutaka; Matsuda, Shintaro; Nagao, Kazuya; Inada, Tsukasa; Murakami, Tomoyuki; Takeuchi, Yasuyo; Yamane, Keiichiro; Toyofuku, Mamoru; Ishii, Mitsuru; Inoko, Moriaki; Ikeda, Tomoyuki; Komasa, Akihiro; Tada, Eiji; Ishii, Katsuhisa; Hotta, Kozo; Higashitani, Nobuya; Jinnai, Toshikazu; Kato, Yoshihiro; Inuzuka, Yasutaka; Maeda, Chiyo; Morikami, Yuko; Saito, Naritatsu; Sakata, Ryuzo; Minatoya, Kenji; Kimura, Takeshi

Comparison of the volatile organic compound recovery rates of commercial active samplers for evaluation of indoor air quality in work environments

用于评估工作环境室内空气质量的商用主动采样器的挥发性有机化合物回收率比较

Yuichi Miyake, Masahiro Tokumura, Qi Wang, Zhiwei Wang, Takashi Amagai